欧洲药典适用性证书数据库（欧盟CEP认证）

专论编号	物质名称	证书持有人	持有人ORG-ID和LOC-ID	证书编号	发布日期	证书状态	到期续期	证书类型	上一程序的结束日期	历史数据程序类型\|结论\|日期
1724	Formoterol fumarate dihydrate	Vamsi Labs Limited Solapur IN	100014747;100023262	R1-CEP 2006-227 - Rev 02	2022/07/28	Valid		Chemical	2023/09/22	Notification\|Accepted - CEP remains valid\|22/09/2023; Notification\|CEP granted\|28/07/2022; Monograph revision\|Accepted - CEP remains valid\|06/05/2022
1745	Carvedilol	SHODHANA LABORATORIES PRIVATE LIMITED Hyderabad IN	100021550;100030244	R1-CEP 2008-259 - Rev 01	2022/07/28	Valid		Chemical	2022/07/28	Minor revision\|CEP granted\|28/07/2022
2420	Tiotropium bromide monohydrate, Micronised, non-micronised	Vamsi Labs Limited Solapur IN	100014747;100023262	R1-CEP 2012-285 - Rev 01	2022/07/28	Valid		Chemical	2023/09/14	Notification\|Rejected\|14/09/2023; Notification\|CEP granted\|28/07/2022
2307	Modafinil	WAVELENGTH ENTERPRISES LTD. Petah Tikva IL	100018877;100050444	R1-CEP 2013-213 - Rev 03	2022/07/28	Valid		Chemical	2022/12/21	Minor revision\|Accepted - CEP remains valid\|21/12/2022; Minor revision\|CEP granted\|28/07/2022; Minor revision\|CEP granted\|02/11/2021; Notification\|CEP granted\|10/06/2020
1558	Propofol	HARMAN FINOCHEM LIMITED Mumbai IN	100011528;100020515	R1-CEP 2015-347 - Rev 00	2022/07/28	Valid		Chemical	2022/07/28	Renewal\|CEP granted\|28/07/2022; Minor revision\|CEP granted\|02/11/2020
394	Hydrochlorothiazide	AMOLI ORGANICS PRIVATE LIMITED Mumbai IN	100016500;100025303	R1-CEP 2016-012 - Rev 00	2022/07/28	Valid		Chemical	2022/07/28	Renewal\|CEP granted\|28/07/2022; Minor revision\|CEP granted\|12/01/2021; Minor revision\|CEP granted\|03/06/2020
2191	Atorvastatin calcium, Process-IV	ZYDUS LIFESCIENCES LIMITED Vadodara IN	100005979;100074301	R0-CEP 2021-079 - Rev 01	2022/07/27	Valid	05/07/2026	Chemical	2022/08/01	Monograph revision\|CEP granted\|01/08/2022; New application\|CEP granted\|05/07/2021
703	Atenolol, ALA route	KOPRAN RESEARCH LABORATORIES LIMITED Mumbai IN		R0-CEP 2021-479 - Rev 00	2022/07/27	Valid	27/07/2027	Chemical	2022/07/27	New application\|CEP granted\|27/07/2022
2531	Clopidogrel hydrogen sulfate, Process II	Zhejiang Charioteer Pharmaceutical Co., Ltd. Xianju CN		R0-CEP 2022-063 - Rev 00	2022/07/27	Valid	27/07/2027	Chemical	2022/07/27	New application\|CEP granted\|27/07/2022
729	Naloxone hydrochloride dihydrate, Process-II	SUN PHARMACEUTICAL INDUSTRIES LIMITED Mumbai IN	100008538	R0-CEP 2022-118 - Rev 00	2022/07/27	Valid	27/07/2027	Chemical	2022/07/27	New application\|CEP granted\|27/07/2022
721	Ibuprofen	IOL CHEMICALS AND PHARMACEUTICALS LTD Ludhiana IN	100017919;100037377	R1-CEP 2008-316 - Rev 05	2022/07/27	Valid		Chemical	2022/07/27	Minor revision\|CEP granted\|27/07/2022; Notification\|CEP granted\|21/06/2021
2404	Drospirenone, Micronised (micro 15)	BAYER AG Leverkusen DE	100000011;100001505	R1-CEP 2009-070 - Rev 02	2022/07/27	Valid		Chemical	2022/07/27	Minor revision\|CEP granted\|27/07/2022
1573	Sumatriptan succinate	MSN PHARMACHEM PRIVATE LIMITED Pashamylaram Village IN	100014794	R1-CEP 2009-096 - Rev 03	2022/07/27	Valid		Chemical	2022/07/27	Minor revision\|CEP granted\|27/07/2022; Minor revision\|CEP granted\|11/03/2021
52	Rifampicin	OLON S.P.A. Rodano IT	100012085;100019537	R1-CEP 2009-275 - Rev 04	2022/07/27	Valid		Chemical	2022/07/27	Minor revision\|CEP granted\|27/07/2022; Major revision\|CEP granted\|24/11/2021
2191	Atorvastatin calcium, Process II	ZYDUS LIFESCIENCES LIMITED Vadodara IN	100005979;100074301	R1-CEP 2011-156 - Rev 05	2022/07/27	Valid		Chemical	2022/07/27	Monograph revision\|CEP granted\|27/07/2022; Notification\|CEP granted\|08/07/2022; Minor revision\|Rejected\|27/01/2021; Major revision\|CEP granted\|31/03/2020
2760	Brimonidine tartrate	Farmak A.S. Olomouc CZ	100012043;100022687	R1-CEP 2014-331 - Rev 01	2022/07/27	Valid		Chemical	2022/07/27	Minor revision\|CEP granted\|27/07/2022; Notification\|Accepted - CEP remains valid\|21/02/2022; Renewal\|CEP granted\|05/07/2021
2541	Quetiapine Fumarate	EGIS Pharmaceuticals PLC Budapest HU	100001091;100001662	R1-CEP 2016-049 - Rev 00	2022/07/27	Valid		Chemical	2023/03/17	Notification\|Accepted - CEP remains valid\|17/03/2023; Renewal\|CEP granted\|27/07/2022; Notification\|Accepted - CEP remains valid\|10/12/2020
2191	Atorvastatin calcium, Process-III	ZYDUS LIFESCIENCES LIMITED Vadodara IN	100005979;100074301	R0-CEP 2020-309 - Rev 01	2022/07/26	Valid		Chemical	2022/07/26	Monograph revision\|CEP granted\|26/07/2022; New application\|CEP granted\|19/02/2021
39	Magnesium Hydroxide	ANHUI POLY PHARM. CO., LTD. Anqing CN		R0-CEP 2022-010 - Rev 00	2022/07/26	Valid	26/07/2027	Chemical	2022/07/26	New application\|CEP granted\|26/07/2022
662	Daunorubicin Hydrochloride	TEVA PHARMACEUTICAL INDUSTRIES LTD Tel Aviv - Jaffa IL	100000702;100060842	R1-CEP 2001-284 - Rev 03	2022/07/26	Valid		Chemical	2023/02/17	Monograph revision\|Accepted - CEP remains valid\|17/02/2023; Minor revision\|CEP granted\|26/07/2022; Notification\|CEP granted\|20/12/2021; Notification\|Accepted - CEP remains valid\|26/06/2020

专论编号 (Monograph Number)
物质名称 (Substance)
证书持有人 (Certificate (CEP) Holder)
证书编号 (Certificate (CEP) Number)
证书类型 (Type CEP)
证书状态 (Status CEP)
发布日期(Issue Date CEP)	-
证书效期(End date CEP)	-